XIFAXAN® (rifaximin) 550 mg tablets logo
  • Full Prescribing Information
  • Important Safety Information

 

XIFAXAN® (rifaximin) 550 mg tablets logo
  • Prescribing Information
  • Important Safety Information
  • Healthcare Professionals
  • Hepatic Encephalopathy Patients
  • About XIFAXAN
  • Resources & Support
  • Living with IBS-D
  • Instant Savings Card
  • Talk to a Doctor Now
  • Newsletter Sign Up
  • Hepatic Encephalopathy Patients
  • For Healthcare Professionals

Site map

  • Home
  • About XIFAXAN
  • Resources & Support
  • Living with IBS-D
  • Instant Savings Card
  • Contact Us
Talk to a doctor now

INDICATION

XIFAXAN® (rifaximin) 550 mg tablets are indicated for the treatment of irritable bowel syndrome with diarrhea (IBS-D) in adults.

IMPORTANT SAFETY INFORMATION

  • XIFAXAN is not for everyone. Do not take XIFAXAN if you have a known hypersensitivity to rifaximin, any of the rifamycin antimicrobial agents, or any of the components in XIFAXAN.
  • If you take antibiotics, like XIFAXAN, there is a chance you could experience diarrhea caused by an overgrowth of bacteria (C. difficile). This can cause symptoms ranging in severity from mild diarrhea to life-threatening colitis. Contact your healthcare provider if your diarrhea does not improve or worsens.
  • Talk to your healthcare provider before taking XIFAXAN if you have severe hepatic (liver) impairment, as this may cause increased effects of the medicine.
  • Tell your healthcare provider if you are taking drugs called P-glycoprotein and/or OATPs inhibitors (such as cyclosporine) because using these drugs with XIFAXAN may lead to an increase in the amount of XIFAXAN absorbed by your body.
  • In clinical studies, the most common side effects of XIFAXAN in IBS-D were nausea (feeling sick to your stomach) and an increase in liver enzymes.
  • XIFAXAN may affect warfarin activity when taken together. Tell your healthcare provider if you are taking warfarin because the dose of warfarin may need to be adjusted to maintain proper blood-thinning effect.
  • If you are pregnant, planning to become pregnant, or nursing, talk to your healthcare provider before taking XIFAXAN because XIFAXAN may cause harm to an unborn baby or nursing infant.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch/ or call 1-800-FDA-1088.

For product information, adverse event reports, and product complaint reports, please contact:

Salix Product Information Call Center
Phone: 1-800-321-4576
Fax: 1-510-595-8183
Email: salixmc@dlss.com

Please click here for full Prescribing Information.

Salix Pharmaceuticals logo
  • Important Safety Information
  • Privacy Policy
  • Legal Notice
  • Contact Us
  • Site Map

The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a healthcare provider. All decisions regarding patient care must be made with a healthcare provider, considering the unique characteristics of the patient.

The product information provided in this site is intended only for residents of the United States. The products discussed herein may have different product labeling in different countries.

Use of this site signifies your agreement to the Legal Notice and Privacy Policy.
Salix Pharmaceuticals
400 Somerset Corporate Boulevard | Bridgewater, NJ 08807

The XIFAXAN 550 mg product and the XIFAXAN trademark are licensed by Alfasigma S.p.A. to Salix Pharmaceuticals or its affiliates. © 2021 Salix Pharmaceuticals or its affiliates. XIFI.0192.USA.20 v3.0

CALIFORNIA RESIDENTS: DO NOT SELL MY PERSONAL INFORMATION

SEE MORE

INDICATION

XIFAXAN® (rifaximin) 550 mg tablets are indicated for the treatment of irritable bowel syndrome with diarrhea (IBS-D) in adults.

IMPORTANT SAFETY INFORMATION

  • XIFAXAN is not for everyone. Do not take XIFAXAN if you have a known hypersensitivity to rifaximin, any of the rifamycin antimicrobial agents, or any of the components in XIFAXAN.
  • If you take antibiotics, like XIFAXAN, there is a chance you could experience diarrhea caused by an overgrowth of bacteria (C. difficile). This can cause symptoms ranging in severity from mild diarrhea to life-threatening colitis. Contact your healthcare provider if your diarrhea does not improve or worsens.
close

You are leaving the XIFAXAN IBS-D Consumer website.

You are now going to be transferred to the Healthcare Providers portal.

Proceed Cancel
close

You are leaving the XIFAXAN IBS-D Consumer website.

Thank you for visiting the XIFAXAN IBS-D consumer website; you are now leaving our site. The website you are about to visit is not affiliated with Salix Pharmaceuticals or its affiliated entities, and is not responsible for the content, format, maintenance, or policies of the website you are about to visit. Salix Pharmaceuticals or its affiliated entities do not monitor non-affiliated websites for accuracy. This link does not imply endorsement or support of any programs, products, or services associated with the website.

Proceed Cancel
close

Talk with a doctor online in just a few easy steps.

Step 1

Step 1

Answer some questions about your symptoms.

Step 2

Step 2

Connect with a doctor to find out if your symptoms are signs of IBS-D.

Step 3

Step 3

If diagnosed and prescribed an Rx, you may pick it up from your local pharmacy (or have it delivered).

You are now leaving XIFAXAN.COM

This third party website is neither owned nor operated by Salix Pharmaceuticals and our Privacy Policy and other rules do not apply. Salix Pharmaceuticals does not endorse or recommend Populus, the qualifications of any physician associated with Populus, or the quality of medical care any of those physicians can provide. Salix Pharmaceuticals cannot guarantee that using Populus will result in your desired outcome. It is your responsibility to assess the qualifications of a potential physician and we recommend that you discuss the benefits and risks of all potential treatments with your doctor. If you agree to the above, click “Acknowledge and Continue” to proceed to the Populus website.

Cancel Acknowledge and Continue